AR and posterior cortical atrophy: In addition, anti-androgen therapy drugs (AAT) such as enzalutamide (ENZ), bicalutamide (BIC) and apalutamide (ARN), competitively blocking androgen binding to androgen receptors (AR) on prostate cells, are also widely used in advanced PCa [14, 15].